1. Home
  2. TWIN vs GBIO Comparison

TWIN vs GBIO Comparison

Compare TWIN & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWIN
  • GBIO
  • Stock Information
  • Founded
  • TWIN 1918
  • GBIO 2016
  • Country
  • TWIN United States
  • GBIO United States
  • Employees
  • TWIN N/A
  • GBIO N/A
  • Industry
  • TWIN Industrial Machinery/Components
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TWIN Industrials
  • GBIO Health Care
  • Exchange
  • TWIN Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • TWIN 169.9M
  • GBIO 145.5M
  • IPO Year
  • TWIN N/A
  • GBIO 2020
  • Fundamental
  • Price
  • TWIN $12.24
  • GBIO $2.49
  • Analyst Decision
  • TWIN
  • GBIO Buy
  • Analyst Count
  • TWIN 0
  • GBIO 4
  • Target Price
  • TWIN N/A
  • GBIO $7.50
  • AVG Volume (30 Days)
  • TWIN 26.1K
  • GBIO 63.7K
  • Earning Date
  • TWIN 10-31-2024
  • GBIO 08-07-2024
  • Dividend Yield
  • TWIN 1.32%
  • GBIO N/A
  • EPS Growth
  • TWIN 5.33
  • GBIO N/A
  • EPS
  • TWIN 0.79
  • GBIO N/A
  • Revenue
  • TWIN $295,127,000.00
  • GBIO $13,174,000.00
  • Revenue This Year
  • TWIN N/A
  • GBIO $99.36
  • Revenue Next Year
  • TWIN N/A
  • GBIO N/A
  • P/E Ratio
  • TWIN $14.85
  • GBIO N/A
  • Revenue Growth
  • TWIN 6.56
  • GBIO 1397.05
  • 52 Week Low
  • TWIN $10.90
  • GBIO $0.86
  • 52 Week High
  • TWIN $18.00
  • GBIO $4.72
  • Technical
  • Relative Strength Index (RSI)
  • TWIN 45.66
  • GBIO 48.59
  • Support Level
  • TWIN $11.72
  • GBIO $2.13
  • Resistance Level
  • TWIN $13.23
  • GBIO $2.49
  • Average True Range (ATR)
  • TWIN 0.46
  • GBIO 0.24
  • MACD
  • TWIN -0.08
  • GBIO -0.02
  • Stochastic Oscillator
  • TWIN 33.99
  • GBIO 44.44

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its products portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: